Management of Severe Asthma in Eosinophilic Granulomatosis with Polyangiitis with Interleukin-5-Targeted Therapies: Current Status and Report of Two Cases
Article in Applied Sciences (November 2022)
The most recent citing publications are shown below. View all 13 publications that cite this research output on Dimensions.
Targeting the interleukin-5 pathway in EGPA: evidence, uncertainties and opportunities
Article in Annals of the Rheumatic Diseases (November 2022)
Effectiveness of Low-Dose Mepolizumab in the Treatment of Eosinophilic Granulomatosis with Polyangiitis (EGPA): A Real-Life Experience
Article in International Archives of Allergy and Immunology (September 2022)